Correlation Between Allogene Therapeutics and Karyopharm Therapeutics
Can any of the company-specific risk be diversified away by investing in both Allogene Therapeutics and Karyopharm Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allogene Therapeutics and Karyopharm Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Allogene Therapeutics and Karyopharm Therapeutics, you can compare the effects of market volatilities on Allogene Therapeutics and Karyopharm Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allogene Therapeutics with a short position of Karyopharm Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allogene Therapeutics and Karyopharm Therapeutics.
Diversification Opportunities for Allogene Therapeutics and Karyopharm Therapeutics
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Allogene and Karyopharm is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Allogene Therapeutics and Karyopharm Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Karyopharm Therapeutics and Allogene Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allogene Therapeutics are associated (or correlated) with Karyopharm Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Karyopharm Therapeutics has no effect on the direction of Allogene Therapeutics i.e., Allogene Therapeutics and Karyopharm Therapeutics go up and down completely randomly.
Pair Corralation between Allogene Therapeutics and Karyopharm Therapeutics
Given the investment horizon of 90 days Allogene Therapeutics is expected to under-perform the Karyopharm Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Allogene Therapeutics is 1.01 times less risky than Karyopharm Therapeutics. The stock trades about -0.02 of its potential returns per unit of risk. The Karyopharm Therapeutics is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 90.00 in Karyopharm Therapeutics on August 29, 2024 and sell it today you would lose (2.00) from holding Karyopharm Therapeutics or give up 2.22% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Allogene Therapeutics vs. Karyopharm Therapeutics
Performance |
| Timeline |
| Allogene Therapeutics |
| Karyopharm Therapeutics |
Allogene Therapeutics and Karyopharm Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Allogene Therapeutics and Karyopharm Therapeutics
The main advantage of trading using opposite Allogene Therapeutics and Karyopharm Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allogene Therapeutics position performs unexpectedly, Karyopharm Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Karyopharm Therapeutics will offset losses from the drop in Karyopharm Therapeutics' long position.| Allogene Therapeutics vs. Heron Therapeuti | Allogene Therapeutics vs. Annexon | Allogene Therapeutics vs. Sangamo Therapeutics | Allogene Therapeutics vs. Beam Therapeutics |
| Karyopharm Therapeutics vs. X4 Pharmaceuticals | Karyopharm Therapeutics vs. Hookipa Pharma | Karyopharm Therapeutics vs. Mereo BioPharma Group | Karyopharm Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |